Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study
- PMID: 26389102
- PMCID: PMC4565176
- DOI: 10.9778/cmajo.20140110
Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study
Abstract
Background: It is recommended that all pregnant women be offered screening for Down syndrome and open neural tube defects, but emerging prenatal tests that are not publicly insured may compromise access. We evaluated screening rates for publicly insured screening tests across health care regions in the province of Ontario and determined whether maternal, provider or regional characteristics are associated with screening uptake.
Methods: We conducted a population-based retrospective cohort study involving pregnant women in Ontario who were at or beyond 16 weeks' gestation in 2007-2009. We ascertained prenatal screening rates using linked health administrative and prenatal screening datasets. We examined maternal, provider and regional characteristics associated with screening uptake. Rate ratios (RRs) were estimated.
Results: Of the 264 737 women included in the study, 62.2% received prenatal screening; uptake varied considerably by region (range 27.8%-80.3%). A greater proportion of women initiated screening in the first rather than the second trimester (50.0% v. 12.2%). Factors associated with lower screening rates included living in a rural area versus an urban area (adjusted rate ratio 0.64, 95% confidence interval [CI] 0.63-0.66), receiving first-trimester care from a family physician or midwife versus an obstetrician (adjusted rate ratio 0.91, 95% CI 0.90-0.92, and 0.40, 95% CI 0.38-0.43, respectively) and being in a lower income quintile (adjusted RR for lowest v. highest 0.95, 95% CI 0.94-0.96). Being an immigrant or a refugee was associated with higher screening rates.
Interpretation: There were significant maternal, provider and regional differences in the uptake of prenatal screening across the province. With discrepancies expected to increase with the emergence of noninvasive prenatal tests paid for out of pocket by many women, policy efforts to reduce barriers to prenatal screening and optimize its availability are warranted.
Conflict of interest statement
Figures


Similar articles
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
Emergency department use by pregnant women in Ontario: a retrospective population-based cohort study.CMAJ Open. 2020 Apr 28;8(2):E304-E312. doi: 10.9778/cmajo.20190154. Print 2020 Apr-Jun. CMAJ Open. 2020. PMID: 32345709 Free PMC article.
-
Maternal factors influencing late entry into prenatal care: a stratified analysis by race or ethnicity and insurance status.J Matern Fetal Neonatal Med. 2019 Oct;32(20):3336-3342. doi: 10.1080/14767058.2018.1463366. Epub 2018 Apr 22. J Matern Fetal Neonatal Med. 2019. PMID: 29631462
-
Breast cancer screening utilization among women from Muslim majority countries in Ontario, Canada.Prev Med. 2017 Dec;105:176-183. doi: 10.1016/j.ypmed.2017.09.008. Epub 2017 Sep 13. Prev Med. 2017. PMID: 28916289
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
Cited by
-
Prenatal Biochemical Screening and a Woman's Long-Term Risk of Cancer: A Population-Based Cohort Study.JNCI Cancer Spectr. 2019 Oct 4;4(1):pkz077. doi: 10.1093/jncics/pkz077. eCollection 2020 Feb. JNCI Cancer Spectr. 2019. PMID: 32110774 Free PMC article.
-
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.Ont Health Technol Assess Ser. 2023 Aug 10;23(4):1-398. eCollection 2023. Ont Health Technol Assess Ser. 2023. PMID: 37637488 Free PMC article.
-
Prenatal biochemical screening and long term risk of maternal cardiovascular disease: population based cohort study.BMJ. 2018 Jul 11;362:k2739. doi: 10.1136/bmj.k2739. BMJ. 2018. PMID: 29997198 Free PMC article.
-
Experiences of perinatal genetic screening for people from migrant and refugee backgrounds: a scoping review.Eur J Hum Genet. 2025 Jun;33(6):701-710. doi: 10.1038/s41431-024-01748-y. Epub 2025 Jan 4. Eur J Hum Genet. 2025. PMID: 39755878 Free PMC article.
-
Association of maternal socioeconomic status and race with risk of congenital heart disease: a population-based retrospective cohort study in Ontario, Canada.BMJ Open. 2022 Feb 1;12(2):e051020. doi: 10.1136/bmjopen-2021-051020. BMJ Open. 2022. PMID: 35105571 Free PMC article.
References
-
- Chitayat D, Langlois S, Wilson RD, et al. Prenatal screening for fetal aneuploidy in singleton pregnancies: CCMG–SOGC clinical practice guideline. J Obstet Gynaecol Can 2011;33:736-50. - PubMed
-
- Benn P, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013;33:622-9. - PubMed
-
- Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968;65:281-393. - PubMed
-
- Raffle A, Gray M. Screening: evidence and practice. New York: Oxford University Press; 2009.
-
- Tapon D. Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA. J Genet Couns 2010;19:112-30. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources